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<BEGIN ABSTRACT> 
Pancreatic cancer is molecularly diverse, with few effective therapies. Increased mutation burden 
and defective DNA repair are associated with response to immune checkpoint inhibitors in 
several other cancer types. We interrogated 385 pancreatic cancer genomes to define 
hypermutation and its causes. Mutational signatures inferring defects in DNA repair were 
enriched in those with the highest mutation burdens. Mismatch repair deficiency was identified 
in 1% of tumors harboring different mechanisms of somatic inactivation of MLH1 and 
MSH2. Defining mutation load in individual pancreatic cancers and the optimal assay for 
patient selection may inform clinical trial design for immunotherapy in pancreatic cancer. 
<END ABSTRACT> 
Keywords: XXX. 
Abbreviations used in this paper: HR, homologous recombination; Mb, megabase; MMR, 
mismatch repair; MSI, microsatellite instability; WGS, whole genome sequencing. 
<BEGIN ARTICLE> 



















 potentially due to the diversity of its genomic landscape.
24 
Recent 
reports link high mutation burden with response to immune checkpoint inhibitors in several 
cancer types.
5
 Defining tumors that are hypermutated with an increased mutation burden and 
understanding the underlying mechanisms in pancreatic cancer has the potential to advance 
therapeutic development, particularly for immunotherapeutic strategies. 
Whole genome sequencing (WGS, n = 180) and whole exome sequencing (n = 205) of 385 
unselected predominantly sporadic pancreatic ductal adenocarcinoma (Supplementary Table 1) 
defined a mean mutation load of 1.8 and 1.1 mutation per megabase (Mb), respectively 
(Supplementary Table 2). Outlier analysis identified 20 samples with the highest mutation 
burden (5.2%, 15 WGS and 5 exome) (Table 1 and Supplementary Figure 1A), 5 of which 
were considered extreme outliers and classified as hypermutated as they contained 12 
somatic mutations/Mb, the defined threshold for hypermutation in colorectal cancer.
6
 
Immunohistochemistry for mismatch repair (MMR) proteins (MSH2, MSH6, MLH1,  and 
PMS2) identified 4 MMR-deficient tumors, all of which were hypermutated (n = 180, Figure 
1). 
KRAS mutation status and histopathologic characteristics have been associated with MMR-
deficient pancreatic tumors.
7
 Of the 4 MMR-deficient tumors in our cohort, 2 were KRAS 
wild-type; 3 had undifferentiated to moderately differentiated histology and one had signet-ring 
component. These features were not predictive of MMR deficiency in our cohort, as 11 
additional nonMMR- deficient tumors had a signet-ring cell component or colloid 
histology, and 131 of 347 assessable tumors had poorly or undifferentiated histology. 
Mutational signature analysis can detect MMR deficiency indirectly based on somatic 
mutations.
8

















and was minimal in MMR intact tumors (Supplementary Figure 1). In addition, 
microsatellite instability (MSI), a hallmark of MMR deficiency in colorectal cancer, was 
detected in all three MMR deficient tumors with WGS using MSIsensor
9
 (Supplementary 
Table 2). MSI was not identified for the fourth MMR deficient sample potentially due to the 
reduced number of microsatellite loci in exome data. 
The underlying causes of MMR deficiency in the 4 cases were private somatic events. For 2 
cases, MSH2 was disrupted by different structural rearrangements, 1 case contained a 
missense MSH2 mutation and the last, methylation of the MLH1 promoter (Figure 1). The 
missense mutation caused an MSH2 splice acceptor site mutation that alters the same 
nucleotide reported to result in a pathogenic skipping of exon 13 in germline studies.
10
 
Hypermethylation of the MLH1 promoter is the predominant mechanism of MSI in sporadic 
colon cancer.
11
 The remaining hypermutated tumor contained an intact MMR pathway, and 
was a cell line (ATCC, CRL-2551) with an unidentified mutational signature, therefore the high 
mutation burden in this sample may be the result of long-term cell culture. 
The 15 samples (11 WGS and 4 exome) identified in the outlier analysis with high mutation 
burden, but not hypermutated (~4 to 12 mutations/Mb) contained no evidence of MMR 
deficiency. Mutational signature analysis of the WGS samples indicated homologous 
recombination (HR) repair deficiency as the most substantial (range, 1.03.4 mutations/Mb) 
contributor to the mutation burden for 8 WGS mutation load outlier tumors. In support of a 
HR defect
4
; 7 of these tumors contained high levels of genomic instability with 200 structural 
variants and mutations in genes involved in HR were present for 6 of 8 cases (Supplementary 
Table 2). In addition, 1 case that had undergone exome sequencing had a somatic BRCA2 

















signature associated with T>G mutations at TT sites previously described in other cancers, 
including esophageal cancer
12 
was the major contributor (3 mutations/Mb) in 2 samples. For 
these 2 and the remaining 4 cases, no potential causative event could be identified. 
Although germline defects in MMR genes are well reported in pancreatic cancer
13
 in our cohort, 
they did not contribute to MMR deficiency even in those with familial pancreatic cancer or a 
personal or family history of Lynch-related tumors. A germline truncating variant was detected 
in PMS2 for 1 case, but did not have loss of the second allele, therefore, had normal 
immunohistochemistry staining and did not display a MMR mutational signature 
(Supplementary Table 2). MMR deficiency is important in the evolution in a small, but 
meaningful proportion of pancreatic cancers with a prevalence of 1% (4 of 385) in our cohort. 
This is consistent with recent studies using the Bethesda polymerase chain reaction panel,
14
 and 
with previous estimates of MSI prevalence of 2%3%. However, in tumors with low epithelial 
content that underwent exome sequencing, the sensitivity of somatic mutation detection is 
reduced, which will affect mutation burden and signature analysis. While cognizant of small 
numbers, immunohistochemistry was the most accurate in defining MMR due to multiple 
genomic mechanisms of MMR gene inactivation. Multiple methods to define MMR deficiency 
may be required for clinical trials that aim to recruit MMR-deficient participants for clinical 
trials examining checkpoint inhibitors or other therapies in pancreatic cancer. Homologous 
recombination-deficient tumors, and those with a novel signature seen in esophageal cancer had 
an increased mutation burden, and need further evaluation as potential patient selection markers 



















The authors would like to thank Cathy Axford, Deborah Gwynne, Mary-Anne Brancato, Clare 
Watson, Michelle Thomas, Gerard Hammond, and Doug Stetner for central coordination of the 
Australian Pancreatic Cancer Genome Initiative, data management, and quality control; Mona 
Martyn-Smith, Lisa Braatvedt, Henry Tang, Virginia Papangelis, and Maria Beilin for 
biospecimen acquisition; and Sonia Grimaldi and Giada Bonizzato of the ARC-Net Biobank for 
biospecimen acquisition. 




To access the supplementary material accompanying this article, visit the online version of 
Gastroenterology at www.gastrojournal.org, and at 
http://dxdoi.org/10.1053/j.gastro.2016.XX.XXX. 
References 
1. Vogelzang NJ, et al. J Clin Oncol 2012;30:88109. 
2. Bailey P, et al. Nature 2016;531:4752. 
3. Biankin AV, et al. Nature 2012;491:399405. 
4. Waddell N, et al. Nature 2015;518:495501. 
5. Le DT, et al. N Engl J Med 2015;372:25092520. 
6. Cancer Genome Atlas Network. Nature 2012;487:330337. 
7. Goggins M, et al. Am J Pathol 1998;152:15011507. 
8. Alexandrov LB, et al. Nature 2013;500:415421. 

















10. Thompson BA, et al. Nat Genet 2014;46:107115. 
11. Boland CR, et al. Gastroenterology 2010;138:20732087 e3. 
12. Nones K, Waddell N, Wayte N, et al. Nat Commun 2014;5. 
13. Grant RC, Selander I, et al. Gastroenterology 2015;148:556564. 
14. Laghi L, et al. PLoS One 2012;7:e46002. 
15. Nakata B, et al. Clin Cancer Res 2002;8:25362540. 
<ARTFN>Author names in bold designate shared co-first authorship. 
 
Figure 1. Molecular mechanisms of MMR deficiency. Immunohistochemistry images (scale bars = 
100 m) indicating loss of staining of MMR proteins in tumor cells (blue) and normal staining 
in adjacent cells (brown) with schematics of underlying genetic etiology. (A) MHS2 absence due 
to a homozygous deletion (ICGC_0076). (B) MHS2 absence and a structural rearrangement 
disrupting the MSH2 locus through insertion of a 27-kb DNA segment (ICGC_0548). (C) MHS2 
absence and a missense acceptor splice site variant at exon 13 (ICGC_0090). (D) MLH1 absence 
through hypermethylation of the promoter region (ICGC_0297). Mean  value of 45 CpG sites in 
the promoter of MLH1 for pancreatic cancer (n = 174) and adjacent non-malignant pancreas tissue 














Table 1. Clinical and histological features and proposed aetiology for highly mutated PDAC tumors (n=20). 
Sample ID Personal and  





















 Proposed aetiology 
Hypermutation (extreme outliers) 
ICGC_0076
† 







28.3 p.G12V MMR (18.3) Scattered 
(131) 
MMR deficiency: >280kb 









27.33 WT MMR (33.4) Scattered 
(75) 
























Cell line with signature: 
etiology unknown. 









0.21 p.G12C N/A N/A MMR deficiency: Somatic 
MSH2 splice site c.2006G>A 










HR deficiency: No germline or 












HR deficiency: Germline 
BRCA2 mutation c.7180A>T, 
p.A2394*. Somatic CN-LOH.  
ICGC_0215
† 
2 FDR lung 












HR deficiency: Germline ATM 
mutation c.7539_7540delAT, 
p.Y2514*. Somatic CN-LOH. 
ICGC_0324 None Ductal 
adenocarcinoma, 
moderately 



































5.63 Normal 0 p.G12D T>G at TT 
sites (3.0) 
Focal (147) T>G at TT sites signature: 
etiology potentially associated 
with DNA oxidation 
ICGC_0006
† 
1 FDR, father 
lung cancer 
Adenocarcinoma 
arising from IPMN, 
moderately 
differentiated 









2 FDR, mother 











HR deficiency: Germline 
BRCA2 c.6699delT, 
p.F2234LfsTer7. Somatic CN 




arising from IPMN, 
moderately 
differentiated 




T>G at TT sites signature: 
etiology potentially associated 
with DNA oxidation 
ICGC_0005
† 







1 p.G12V HR deficiency 
(1.1) 
Focal (95) HR deficiency: No germline or 










HR deficiency: potentially 
linked to Somatic RPA1 
c.273G>T, p.R91S 

















HR deficiency: Germline 
BRCA2 c.7068_7069delTC, 
p.L2357VfsTer2. Somatic CN 
loss - 1 copy. 





0.03 p.G12R N/A N/A HR deficiency: Somatic BRCA2 
c.7283T>A, p.L2428* 


















† Sample sequenced by whole genome sequencing (WGS), other samples by exome sequencing  



























Supplementary Materials, Methods and Acknowledgements 
Patient and clinical data: The cohort consisted of 385 patients with histologically 
verified pancreatic exocrine carcinoma, prospectively recruited between 2006 and 
2013 through the Australian Pancreatic Cancer Genome Initiative (APGI; 
www.pancreaticcancer.net.au) as part of the International Cancer Genome 
Consortium (ICGC)1. Ethical approval was granted at all treating institutions and 
individual patients provided informed consent upon entry to the study. The clinico-
pathological information for the cohort is described in (Supplementary Table 1); and 
the global mutation profile has previously been reported for some of these tumors 
(Supplementary Table 2). 
Genomic sequencing: Tumor and normal DNA were extracted after histological 
review from fresh frozen tissue samples collected at the time of surgical resection or 
biopsy as previously described2. Tumor cellularity was determined from SNP array 
data using qpure3. Tumors with epithelial content ≥ 40% underwent whole genome 
sequencing (WGS), lower cellularity tumors underwent whole exome sequencing. 
DNA from patient derived pancreas cell lines and matched normal was also 
extracted. Exome and WGS were performed using paired 100bp reads on the 
Illumina HiSeq 2000 as previously described2, 4. 
Copy number and structural variation analysis: Regions of germline and somatic 
copy number change were detected using Illumina SNP BeadChips with GAP5. 
Somatic structural variants were identified from WGS reads using the qSV tool4, 6.  
Germline and somatic single nucleotide and indel variant identification: Single 
nucleotide variants were called using 2 variant callers: qSNP7 and GATK8. Mutations 
identified by both callers or, those that were unique to a caller but verified by an 













subsequent analyses. Small indels (<200 bp) were identified using Pindel9 and each 
indel was visually inspected in the Integrative Genome Browser (IGV).  
Identification of samples with somatic hypermutation: The distribution of the 
total number of small somatic mutations (coding and non-coding single nucleotide 
and indel variants) identified per megabase for exome and WGS sequence data 
were analysed separately. The group of samples with high mutation load, at the top 
of each distribution, were defined as the upper distribution outliers for mutations per 
megabase i.e. ≥ 75th centile + (1.5 x the interquartile range (IQR)). The threshold for 
detecting outliers in the exome and WGS groups was 3.4 and 4.2 mutations/Mb 
respectively. From within the highly mutated set of tumors, hypermutated samples 
were identified as those with a mutation rate exceeding the thresholds for extreme 
distribution outliers (≥ 75th centile + (5x the IQR)) of 7.4 and 8.1 mutations/Mb for 
exome and WGS sequencing respectively. 
MMR deficiency: a) Genomic analysis: MSIsensor was used to detect microsatellite 
instability by directly comparing microsatellite repeat lengths between paired normal 
and tumor sequencing data10. A MSIsensor score of > 3.5% of somatic 
microsatellites with repeat length shifts was the detection threshold used to indicate 
MSI as published for endometrial cancer10. This correlated well with the 5 and 7 
microsatellite panels recommended in the Bethesda guidelines10, 11; b) 
Immunohistochemistry: Tissue microarrays were constructed using at least three 
1mm FFPE tumor cores. Immunohistochemistry for MSH6 and PMS2 proteins was 
performed on TMA sections as a screen for MMR deficiency due to MMR proteins 
forming heterodimers with concordant mismatch repair loss (i.e., loss of MLH1 and 
PMS2 or loss of MSH2 and MSH6)12. Immunohistochemistry on full tumor sections 













in core sections. The IHC was performed as previously described12 and scored by a 
senior pathologist.  
Mutational signature analysis: Somatic mutational signatures were extracted from 
the whole genome sequenced samples using the framework previously described13. 
High confidence somatic substitutions were classified by the substitution change and 
sequence context i.e. the type of immediately neighbouring bases to the variant. The 
frame work processes the counts of somatic mutations at each context within each 
sample using nonnegative factorisation to produce the different signature profiles 
that are present in the data. The profiles identified were matched against reported 
signatures from the Cancer of Somatic Mutations in Cancer (COSMIC: 
http://cancer.sanger.ac.uk/cosmic/signatures). The major contributory signatures, 
defined as the mutational signature with the highest number of contributing somatic 
substitution variants is reported for highly mutated whole genome samples. 
Methylation arrays: Bisulfite converted whole-genome amplified DNA was 
hybridized to Infinium Human Methylation 450K Beadchips according to the 
manufacturers protocol (Illumina). Methylation arrays were performed on DNA from 
174 PDAC samples which was compared to DNA from 29 adjacent non-malignant 
pancreata. A subset of the methylation data has been previously published14. We 
examined the data for evidence of tumor specific hypermethylation of the promoter 
region of MLH1 and MSH2 genes. The methylation array data has been deposited 
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N  = 373 Median DSS P  value
Variable No. (%) (mo) (logrank)
Sex
    Male 198 (53.1) 18.8
    Female 175 (46.9) 27.4 0.0411
Age (years)
    Mean 66.6
    Median 67.5
    Range 33 – 90
Outcome
    Follow-up (months) 0 – 94.9
    Median follow-up 15.9
    Death PC 237 (63.5)
    Death other 9  (2.4)
    Surgical death (<30 days) 14 (3.8)
    Alive 108 (29.0)
         - without disease 70 (18.8)
         - with disease 25 (6.7)
         - status unknown 13 (3.5)
    Lost to Follow-up 5 (1.3)
Histopathological subtype
PDAC 331 (88.7)
IPMN with invasion 17 (4.6)
Adenosquamous 13 (3.5)
Colloid carcinoma 6 (1.6)




    Ia 7 (1.9)
    Ib 13 (3.5) 26.8
    IIa 69 (18.5)
    IIb 263 (70.5) 21.3
    III 3 (0.8) 21.8




    T1 8 (2.1)
    T2 35 (9.4) 20.3
    T3 322 (86.3)
    T4 5 (1.3) 20.5 0.2302
Missing 3 (0.8)
N Stage













    N0 91 (24.4) 27.8




    Well 17 (4.6)
    Moderate 209 (56.0) 27.4
    Poor 127 (34.0)
    Undifferentiated 11 (2.9) 15.1 <0.0001
    Missing 9  (2.4)
Tumor location
    Head 298 (79.9) 23.1
    Body/Tail 71 (19.0) 16.1 0.0128
Missing 3 (0.8)
Tumor size
    ≤ 20mm 42 (11.3) 29.8




    Clear 263 (70.5) 23.9
    Microscopically involved 92 (24.7) 16 0.0015
    Macroscopically involved 9 (2.4)
    Missing 9 (2.4)
Perineural Invasion
    Negative 41 (11.0) 34
    Positive 303 (81.2) 20 0.0057
    Missing 29 (7.8)
Vascular Invasion
    Negative 131 (35.1) 30
    Positive 218 (58.4) 17.2 <0.0001
     Missing 24 (6.4)
Clinical and Family History
  Previous malignancy 54 (14.5)
        1 prior malignancy 49 (13.1)
        2 prior malignancies 5 (1.3)
        Previous CRC 8 (2.1)
        Previous endometrial cancer 3 (0.8)
  Family history of cancer ≥1 FDR 103 (27.6)
    Familial PC 26 (7.0)
       1 FDR PC 25 (6.7)
       2 FDR PC 1 (0.3)
    Family history of CRC in ≥1 FDR 26 (7.0)
       2 FDR + 1 SDR 1 (0.3)
       2 FDR 3 (0.8)
       1 FDR + 3 SDR 1 (0.3)
       1 FDR 21 (5.6)













      1 FDR 4 (1.1)
Non-resected PDAC patients
N  = 12
Variable No. (%)
Sex
    Male 8 (66.7) 7.2
    Female 4 (33.3) 5.1 0.0528
Age (years)
    Mean 60.3
    Median 60.5
    Range 42 - 76
Outcome
    Follow-up (months) 2.7 – 36.8
    Median follow-up 6.6
    Death PC 11 (91.7)
    Death other 0





    III 5 (41.7) 15.6
    IV 6 (50.0) 6 0.4386
    Missing 1
Clinical and Family History
Previous malignancy 0
Family history of cancer
    Familial PC 1 (8.3)
    Family history of CRC 0
 Family history of endometrial cancer 0
c 
Survival analysis performed on Well/Moderate Vs Poor/undifferentiated
d
 R2 resection excluded from survival analysis
a
 Survival analysis compared stage 1 vs 2 vs 3 vs 4
b
 Survival analysis performed on T stage 1 and 2 vs 3 and 4
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Variants in DNA repair associated 
genes Somatic Mut/Mb MSIsensor score (%)
Methylation array 
0=no; 1=yes
MMR IHC 0=no; 
1=yes













signature MMR Deficiency signature (mutations/MB)Dea ination signature (mutations/MB)Unknown signature (mutations/MB)T>G at TT sites signature (mutations/MB)HR Deficiency signature (mutations/MB)APOBEC signature (mutations/MB)
ICGC_0297 Genome NA hypermutated 67.82 80.66 60.617 27.33 1 1 0 2 2 MSH2, 2 MSH6, 0 MLH1, 0 PMS2MMR Deficiency 33.364 0.000 1.262 0.302 2.312 0.405
ICGC_0076 Genome Waddell et al 2015; Bailey et al 2016 hypermutated 49.07 100.00 38.546 28.30 0 1 2 0 0 MSH2, 0 MSH6, 2 MLH1, 2 PMS2MMR Deficiency 18.332 5.188 0.286 0.683 1.172 0.626
ICGC_0548 Genome Waddell et al 2015; Bailey et al 2016 hypermutated 60.13 99.70 30.130 17.47 0 1 2 0 0 MSH2, 0 MSH6, 2 MLH1, 2 PMS2MMR Deficiency 16.608 4.417 0.000 0.003 0.000 0.000
ICGC_0328 Genome Waddell et al 2015; Bailey et al 2016 hypermutated 52.21 99.40 16.629 3.20 0 1 2 2 2 MSH2, 2 MSH6, 2 MLH1, 2 PMS2Unknown 1.280 0.262 11.866 1.559 0.029 0.212
ICGC_0090 Exome Bailey et al 2016 hypermutated 158.93 13.36 12.900 0.21 1 1 2 0 0 MSH6, 0 MSH2, 2 PMS2, 2 MLH1N/A N/A N/A N/A N/A N/A N/A
ICGC_0290 Genome Waddell et al 2015; Bailey et al 2016 highly mutated 66.10 82.53 Germline BRCA2 c.7180A>T, p.Arg2394Ter 6.538 0.07 1 0 HR Deficiency 0.708 0.156 0.308 0.544 3.064 1.139
ICGC_0054 Genome Waddell et al 2015; Bailey et al 2016 highly mutated 37.41 100.00 6.522 0.69 1 1 2 2 HR Deficiency 0.356 0.240 0.156 0.154 1.330 0.228
ICGC_0215 Genome Waddell et al 2015; Bailey et al 2016 highly mutated 76.49 71.56 Germline ATM c.7539_7540delAT, p.Tyr2514Ter 6.275 0.01 1 1 2 2 2 MSH2, 1 MSH6, 2 MLH1, 2 PMS2HR Deficiency 1.136 1.107 0.203 0.879 1.913 0.525
ICGC_0324 Exome Bailey et al 2016 highly mutated 188.13 36.85 6.240 0.00 0 1 2 2 2 MSH2, 2 MSH6, 2 MLH1, 2 PMS2N/A N/A N/A N/A N/A N/A N/A
ICGC_0034 Genome Waddell et al 2015; Bailey et al 2016 highly mutated 57.82 98.47 Germline BRCA2 c.5237_5238insT, p.Asn1747Ter 6.087 4.02 0 1 2 2 HR Deficiency 1.146 0.001 0.282 0.252 3.359 0.734
ICGC_0131 Genome Waddell et al 2015; Bailey et al 2016 highly mutated 90.82 46.55 5.632 0.00 1 1 2 2 T>G at TT sites 0.108 1.229 0.271 3.019 0.384 0.162
ICGC_0006 Genome Waddell et al 2015; Bailey et al 2016 highly mutated 63.46 69.69 Somatic BRCA2 chr13:g.32913837->A 5.291 0.01 1 1 2 2 HR Deficiency 0.671 0.569 0.221 1.008 1.219 0.988
ICGC_0321 Genome Waddell et al 2015; Bailey et al 2016 highly mutated 63.23 63.58 Germline BRCA2 c.6699delT, p.Phe2234LeufsTer74.788 0.00 1 0 Normal Bethesda PCR panel HR D ficiency 0.744 0.384 0.289 0.155 2.055 0.508
ICGC_0309 Genome Waddell et al 2015; Bailey et al 2016 highly mutated 56.79 79.53 4.740 0.03 1 1 2 2 T>G at TT sites 0.246 0.259 0.002 3.081 0.035 0.891
ICGC_0005 Genome Waddell et al 2015; Bailey et al 2016 highly mutated 48.12 99.85 4.721 1.00 0 0 Deamination 0.315 1.418 0.410 0.269 1.075 0.595
ICGC_0016 Genome Waddell et al 2015; Bailey et al 2016 highly mutated 50.09 99.20 4.607 3.03 0 1 2 2 HR Deficiency 0.868 0.660 0.418 0.251 1.668 0.331
GARV_0668 Genome Bailey et al 2016 highly mutated 63.30 99.14 Germline BRCA2 c.7068_7069delTC, p.Leu2357ValfsTer24.300 2.19 0 0 HR Deficiency 0.825 0.310 0.428 0.142 1.623 0.289
ICGC_0046 Exome Bailey et al 2016 highly mutated 263.59 30.17 Yes Not detected 4.300 0.00 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0291 Exome Bailey et al 2016 highly mutated 213.38 44.69 Somatic BRCA2 c.7283T>A, p.L2428* 3.840 0.03 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0256 Exome Bailey et al 2016 highly mutated 182.45 43.81 3.720 0.06 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0089 Genome Waddell et al 2015; Bailey et al 2016 other 68.28 100.00 4.166 1.52 0 1 2 2 N/A 0.389 0.449 0.408 0.072 1.697 0.882
ICGC_0149 Genome Waddell et al 2015; Bailey et al 2016 other 82.52 69.52 Yes Germline PALB2 c.172_175delTTGT, p.Gln60ArgfsTer74.021 0.02 1 0 N/A 0.476 0.754 0.270 0.118 1.446 0.385
ICGC_0192 Genome Bailey et al 2016 other 74.32 53.95 Germline BRCA2 c.9294C>G, p.Tyr3098Ter 3.709 0.00 1 1 2 2 N/A 0.481 0.237 0.173 0.111 1.990 0.322
GARV_0669 Genome Bailey et al 2016 other 61.34 99.34 3.547 0.91 0 0 N/A 0.420 0.561 0.477 0.272 1.075 0.351
ICGC_0420 Genome Waddell et al 2015; Bailey et al 2016 other 94.67 65.55 3.538 0.02 1 0 N/A 0.173 0.892 0.194 0.167 0.397 1.427
ICGC_0303 Genome Waddell et al 2015; Bailey et al 2016 other 53.64 65.78 3.478 0.01 1 1 2 2 N/A 0.604 0.095 0.193 0.257 1.691 0.261
ICGC_0384 Genome Bailey et al 2016 other 59.94 69.30 3.447 0.01 1 0 N/A 0.360 0.401 0.238 0.108 1.844 0.151
GARV_0667 Genome Bailey et al 2016 other 42.86 99.58 3.385 0.26 0 0 N/A 0.297 0.782 0.325 0.164 1.220 0.306
ICGC_0088 Genome Waddell et al 2015; Bailey et al 2016 other 92.83 62.90 Germline PMS2 c.1738A>T, p.Lys580Ter 3.314 0.05 1 1 2 2 N/A 0.494 0.897 0.232 0.129 0.767 0.470
ICGC_0042 Genome Waddell et al 2015; Bailey et al 2016 other 72.76 99.31 3.285 1.07 0 1 2 2 N/A 0.255 0.594 0.244 0.192 0.520 1.136
ICGC_0134 Genome Waddell et al 2015; Bailey et al 2016 other 69.65 50.51 3.279 0.01 1 1 2 2 N/A 0.432 0.688 0.205 0.687 0.580 0.413
ICGC_0227 Genome Bailey et al 2016 other 78.22 62.62 Yes Not detected 3.262 0.00 1 1 2 2 N/A 0.288 0.270 0.228 0.060 1.094 1.104
ICGC_0174 Exome Bailey et al 2016 other 170.69 15.31 3.200 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0033 Genome Waddell et al 2015; Bailey et al 2016 other 72.84 99.13 Somatic BRCA2 chr13:g.32971184AAGTTAATGTAAACTC>-3.075 1.65 0 1 2 2 N/A 0.312 0.337 0.212 0.796 1.006 0.122
ICGC_0114 Genome Waddell et al 2015; Bailey et al 2016 other 66.32 82.84 3.062 0.05 1 0 N/A 0.477 0.487 0.107 0.090 1.322 0.358
ICGC_0137 Genome Waddell et al 2015; Bailey et al 2016 other 71.74 98.78 3.054 1.31 0 0 N/A 0.288 0.865 0.268 0.219 0.606 0.468
ICGC_0002 Genome Waddell et al 2015; Bailey et al 2016 other 60.55 54.82 3.044 0.00 1 1 2 2 N/A 0.443 0.789 0.258 0.347 0.520 0.126
ICGC_0418 Exome Bailey et al 2016 other 235.31 18.28 3.040 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
GARV_0665 Genome Bailey et al 2016 other 43.06 99.28 3.026 0.26 0 0 N/A 0.374 0.831 0.250 0.145 0.787 0.338
GARV_0666 Genome Bailey et al 2016 other 67.47 98.80 2.987 0.50 0 0 N/A 0.424 0.557 0.293 0.128 1.079 0.217
ICGC_0319 Exome Bailey et al 2016 other 208.69 22.43 2.980 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0085 Genome Bailey et al 2016 other 52.34 99.81 2.960 0.50 0 0 N/A 0.319 0.589 0.187 0.037 1.202 0.171
ICGC_0087 Genome Waddell et al 2015; Bailey et al 2016 other 90.74 43.48 Somatic PALB2 chr16:g.23641174GACT>- 2.909 0.00 1 1 2 2 N/A 0.232 1.165 0.275 0.466 0.265 0.178
ICGC_0052 Genome Waddell et al 2015; Bailey et al 2016 other 59.71 52.27 Yes Not detected 2.900 0.00 1 1 2 2 N/A 0.083 0.515 0.067 0.008 0.001 2.011
ICGC_0423 Exome Bailey et al 2016 other 163.72 41.43 2.900 0.01 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0037 Genome Waddell et al 2015; Bailey et al 2016 other 84.95 69.67 2.836 0.04 1 1 2 2 N/A 0.146 1.279 0.325 0.069 0.463 0.178
ICGC_0140 Genome Waddell et al 2015; Bailey et al 2016 other 66.19 88.54 2.829 0.18 1 1 2 2 N/A 0.325 0.657 0.121 0.521 0.629 0.329
ICGC_0150 Genome Bailey et al 2016 other 60.61 80.52 2.813 0.02 1 1 2 2 N/A 0.281 0.609 0.203 0.429 0.864 0.182
ICGC_0119 Genome Waddell et al 2015; Bailey et al 2016 other 51.67 99.13 2.767 0.14 0 1 2 2 N/A 0.284 0.804 0.043 0.097 0.265 0.982
ICGC_0077 Genome Waddell et al 2015; Bailey et al 2016 other 58.18 99.13 2.761 1.61 0 1 2 2 2 MSH6, 2 MSH2, 2 PMS2, 2 MLH1N/A 0.226 0.789 0.231 0.190 0.940 0.104
ICGC_0338 Genome Waddell et al 2015; Bailey et al 2016 other 68.72 97.91 2.722 3.06 1 0 Normal Bethesda PCR panel N/A 0.436 0.243 0.253 0.035 1.170 0.366
ICGC_0178 Exome Bailey et al 2016 other 175.28 15.40 Yes Not detected 2.720 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0392 Genome Bailey et al 2016 other 85.35 57.74 2.714 0.02 1 0 N/A 0.386 0.597 0.501 0.063 0.694 0.155
ICGC_0244 Exome Bailey et al 2016 other 152.00 40.99 2.640 0.02 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0532 Genome Waddell et al 2015; Bailey et al 2016 other 66.79 99.43 2.564 2.76 0 0 N/A 0.293 0.530 0.206 0.087 0.875 0.367
ICGC_0395 Genome Bailey et al 2016 other 91.20 67.01 2.533 0.01 1 1 2 2 N/A 0.160 0.513 0.101 1.078 0.473 0.011
ICGC_0422 Exome Bailey et al 2016 other 170.37 32.22 2.500 0.02 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0367 Genome Bailey et al 2016 other 93.14 73.80 2.498 0.25 0 0 N/A 0.113 0.767 0.182 0.088 0.509 0.584
ICGC_0512 Genome Bailey et al 2016 other 65.38 48.34 2.493 0.00 1 0 N/A 0.077 0.630 0.117 1.130 0.235 0.101
ICGC_0194 Exome Bailey et al 2016 other 228.50 39.28 Yes Not detected 2.460 0.01 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0021 Genome Bailey et al 2016 other 50.75 47.04 2.441 0.01 1 1 2 2 N/A 0.047 1.023 0.221 0.401 0.368 0.222
ICGC_0067 Genome Bailey et al 2016 other 113.96 30.52 Yes Not detected 2.438 0.00 1 1 2 1 2 MSH6,  2 MSH2, 2 PMS2, 2 MLH1N/A 0.459 0.800 0.226 0.246 0.809 0.120
ICGC_0286 Exome Bailey et al 2016 other 164.91 16.54 2.420 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0341 Exome Bailey et al 2016 other 271.49 43.49 2.420 0.01 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0059 Genome Waddell et al 2015; Bailey et al 2016 other 68.39 69.56 Yes Not detected 2.416 0.01 1 1 2 2 N/A 0.010 1.445 0.202 0.051 0.315 0.080
ICGC_0542 Genome Bailey et al 2016 other 69.71 67.14 2.403 0.00 0 0 N/A 0.167 0.778 0.227 0.060 0.788 0.172
ICGC_0228 Exome Bailey et al 2016 other 217.71 38.80 2.380 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0035 Genome Waddell et al 2015; Bailey et al 2016 other 47.75 48.71 2.372 0.00 1 1 2 2 N/A 0.146 0.846 0.202 0.180 0.494 0.261
ICGC_0118 Genome Waddell et al 2015; Bailey et al 2016 other 56.65 99.10 Yes Not detected 2.352 0.39 0 1 2 2 N/A 0.264 0.450 0.172 0.499 0.561 0.169
ICGC_0069 Genome Waddell et al 2015; Bailey et al 2016 other 59.02 66.17 2.339 0.01 1 1 2 2 N/A 0.475 0.118 0.094 1.014 0.303 0.158
ICGC_0044 Exome Bailey et al 2016 other 218.57 21.74 2.320 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0061 Genome Waddell et al 2015; Bailey et al 2016 other 51.25 63.89 Yes Germline BRCA2 c.5409_5410delTG, p.Val1804LysfsTer22.307 0.00 1 1 2 2 N/A 0.348 0.085 0.123 0.032 1.123 0.335
ICGC_0109 Genome Waddell et al 2015; Bailey et al 2016 other 85.70 54.10 2.301 0.00 1 1 2 2 N/A 0.199 0.835 0.248 0.029 0.364 0.393
ICGC_0093 Exome Bailey et al 2016 other 235.97 40.21 2.280 0.03 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0141 Genome Waddell et al 2015; Bailey et al 2016 other 39.56 63.30 2.240 0.01 1 0 N/A 0.146 0.497 0.164 0.019 0.425 0.069
ICGC_0207 Genome Waddell et al 2015; Bailey et al 2016 other 62.01 64.30 2.231 0.00 1 0 N/A 0.242 0.835 0.207 0.126 0.468 0.098
ICGC_0529 Genome Bailey et al 2016 other 75.92 70.71 2.222 0.00 1 0 N/A 0.029 1.046 0.141 0.194 0.459 0.125
ICGC_0225 Exome Bailey et al 2016 other 119.93 44.17 Yes Not detected 2.220 0.00 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0374 Exome Bailey et al 2016 other 106.26 39.05 2.220 0.00 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0531 Exome Bailey et al 2016 other 209.79 17.12 2.220 0.01 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0327 Genome Waddell et al 2015; Bailey et al 2016 other 78.26 99.04 2.218 0.93 0 0 N/A 0.160 0.502 0.588 0.017 0.620 0.112
ICGC_0329 Genome Waddell et al 2015; Bailey et al 2016 other 73.51 100.00 2.202 0.10 0 0 N/A 0.070 0.963 0.186 0.023 0.449 0.306
ICGC_0366 Exome Bailey et al 2016 other 108.45 33.17 2.200 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
Supplementary Table 2: Summary of the somatic mutation load in the 385 PC cohort and the classification by somatic hypermutation, MSIsensor and immunohistochemistry.
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ICGC_0051 Genome Waddell et al 2015; Bailey et al 2016 other 70.82 73.99 2.189 0.01 1 1 2 2 N/A 0.133 0.230 0.088 0.044 0.258 0.122
ICGC_0376 Genome Bailey et al 2016 other 87.97 56.31 2.171 0.00 1 0 N/A 0.304 0.338 0.116 0.064 0.885 0.250
ICGC_0086 Genome Bailey et al 2016 other 40.40 100.00 Yes Not detected 2.170 0.28 0 0 N/A 0.068 0.459 0.115 0.597 0.561 0.067
ICGC_0375 Genome Bailey et al 2016 other 45.90 65.14 2.169 0.00 1 0 N/A 0.268 0.252 0.126 0.032 0.918 0.330
ICGC_0277 Exome Bailey et al 2016 other 170.88 37.43 2.160 0.01 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0406 Genome Bailey et al 2016 other 100.13 64.21 2.157 0.01 1 1 2 2 N/A 0.146 0.686 0.249 0.093 0.636 0.117
ICGC_0282 Exome Bailey et al 2016 other 227.47 46.09 2.140 0.01 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0326 Genome Waddell et al 2015; Bailey et al 2016 other 61.27 59.10 2.126 0.01 1 1 2 2 N/A 0.191 0.712 0.362 0.075 0.416 0.132
ICGC_0229 Exome Bailey et al 2016 other 186.65 15.43 2.120 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0060 Exome Bailey et al 2016 other 356.00 34.03 2.100 0.01 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0316 Exome Bailey et al 2016 other 196.53 39.67 2.100 0.01 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0304 Genome Waddell et al 2015; Bailey et al 2016 other 69.73 73.29 2.092 0.01 1 1 2 2 N/A 0.204 0.829 0.160 0.058 0.439 0.154
GARV_0662 Genome Bailey et al 2016 other 58.65 99.06 2.077 0.73 0 0 N/A 0.115 1.041 0.133 0.043 0.289 0.215
ICGC_0549 Genome Waddell et al 2015; Bailey et al 2016 other 82.92 99.41 2.074 0.38 0 0 N/A 0.092 0.860 0.326 0.022 0.465 0.058
ICGC_0523 Exome Bailey et al 2016 other 152.65 34.19 2.060 0.01 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0526 Genome Bailey et al 2016 other 69.35 61.96 2.041 0.00 1 0 N/A 0.096 0.742 0.170 0.185 0.366 0.245
ICGC_0285 Genome Waddell et al 2015; Bailey et al 2016 other 58.38 78.83 2.028 0.02 1 0 N/A 0.172 0.731 0.129 0.052 0.614 0.119
ICGC_0056 Exome Bailey et al 2016 other 212.98 14.91 2.020 0.02 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0499 Exome Bailey et al 2016 other 174.05 22.62 2.020 0.03 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0393 Genome Bailey et al 2016 other 87.71 52.43 2.008 0.00 1 0 N/A 0.192 0.819 0.146 0.074 0.318 0.174
ICGC_0075 Genome Waddell et al 2015; Bailey et al 2016 other 59.62 81.34 2.006 0.01 1 1 2 2 N/A 0.218 0.283 0.132 0.028 0.669 0.492
ICGC_0065 Exome Bailey et al 2016 other 164.33 41.85 2.000 0.00 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0510 Genome Bailey et al 2016 other 62.47 52.51 1.991 0.00 1 0 N/A 0.296 0.328 0.105 0.042 0.541 0.502
ICGC_0322 Exome Bailey et al 2016 other 313.88 38.58 Yes Not detected 1.980 0.01 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0522 Genome Bailey et al 2016 other 74.65 58.36 1.974 0.00 1 0 N/A 0.075 0.803 0.164 0.041 0.513 0.175
GARV_0661 Genome Bailey et al 2016 other 67.30 99.45 1.971 0.39 0 0 N/A 0.106 0.826 0.242 0.039 0.310 0.222
ICGC_0153 Genome Waddell et al 2015; Bailey et al 2016 other 70.62 80.06 1.945 0.00 1 1 2 2 N/A 0.021 1.109 0.164 0.046 0.200 0.183
ICGC_0276 Exome Bailey et al 2016 other 163.26 20.65 1.940 0.02 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0528 Exome Bailey et al 2016 other 209.22 38.43 1.940 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0511 Exome Bailey et al 2016 other 210.77 18.04 1.920 0.01 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0283 Genome Waddell et al 2015; Bailey et al 2016 other 64.29 58.71 1.915 0.00 1 0 N/A 0.176 0.656 0.140 0.065 0.523 0.122
ICGC_0245 Exome Bailey et al 2016 other 179.10 40.85 1.900 0.13 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0349 Exome Bailey et al 2016 other 209.19 33.79 1.900 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0036 Genome Waddell et al 2015; Bailey et al 2016 other 46.08 72.18 Yes Not detected 1.896 0.02 1 1 2 2 N/A 0.238 0.570 0.222 0.371 0.747 0.139
ICGC_0072 Genome Waddell et al 2015; Bailey et al 2016 other 26.80 100.00 1.881 0.37 0 0 N/A 0.213 0.623 0.245 0.077 0.373 0.079
ICGC_0013 Exome Bailey et al 2016 other 202.49 22.68 1.880 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0273 Exome Bailey et al 2016 other 172.49 18.69 1.880 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0029 Genome Bailey et al 2016 other 66.47 71.16 1.875 0.00 0 1 2 2 N/A 0.149 0.806 0.170 0.036 0.305 0.264
ICGC_0364 Genome Bailey et al 2016 other 71.09 52.97 1.867 0.00 0 1 2 2 N/A 0.144 0.728 0.204 0.038 0.377 0.167
ICGC_0419 Genome Bailey et al 2016 other 94.27 49.82 1.862 0.00 1 1 2 2 N/A 0.155 0.517 0.104 0.057 0.469 0.365
GARV_0659 Genome Bailey et al 2016 other 62.73 98.97 1.862 1.06 0 0 N/A 0.250 0.509 0.175 0.023 0.533 0.197
ICGC_0386 Exome Bailey et al 2016 other 127.39 32.55 1.860 0.01 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0415 Genome Bailey et al 2016 other 76.31 48.50 1.860 0.00 1 0 N/A 0.040 0.684 0.107 0.022 0.203 0.202
ICGC_0527 Exome Bailey et al 2016 other 212.52 30.09 1.860 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0524 Exome Bailey et al 2016 other 215.68 21.72 1.840 0.03 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0008 Genome Waddell et al 2015; Bailey et al 2016 other 45.46 96.22 1.826 0.25 0 1 2 2 N/A 0.271 0.667 0.146 0.066 0.409 0.034
ICGC_0043 Exome Bailey et al 2016 other 313.59 30.71 1.820 0.00 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0236 Exome Bailey et al 2016 other 132.92 27.36 1.820 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0296 Genome Waddell et al 2015; Bailey et al 2016 other 69.48 63.53 1.816 0.01 1 1 2 2 N/A 0.060 0.811 0.165 0.040 0.466 0.071
ICGC_0099 Genome Bailey et al 2016 other 88.05 46.31 1.809 0.00 1 1 2 2 N/A 0.146 0.441 0.078 0.377 0.415 0.162
ICGC_0107 Exome Bailey et al 2016 other 170.28 16.17 1.800 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0015 Exome Bailey et al 2016 other 205.58 19.74 1.780 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0105 Genome Waddell et al 2015; Bailey et al 2016 other 74.48 83.08 1.780 0.02 1 1 2 2 N/A 0.143 0.750 0.154 0.045 0.382 0.089
ICGC_0103 Genome Waddell et al 2015; Bailey et al 2016 other 64.16 57.97 1.762 0.00 1 1 2 2 N/A 0.020 0.953 0.147 0.029 0.396 0.017
ICGC_0416 Exome Bailey et al 2016 other 199.33 30.21 1.760 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0208 Exome Bailey et al 2016 other 224.13 12.69 1.740 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0536 Genome Bailey et al 2016 other 57.84 42.64 1.722 0.00 1 0 N/A 0.088 0.847 0.127 0.095 0.351 0.088
ICGC_0339 Exome Bailey et al 2016 other 184.28 28.72 1.720 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
GARV_0672 Genome Bailey et al 2016 other 66.63 99.33 1.716 0.51 0 0 N/A 0.140 0.612 0.152 0.035 0.405 0.104
GARV_0663 Genome Bailey et al 2016 other 60.10 99.36 1.714 0.26 0 0 N/A 0.197 0.618 0.109 0.054 0.309 0.234
ICGC_0063 Genome Waddell et al 2015; Bailey et al 2016 other 61.35 81.61 1.712 0.01 1 1 2 2 N/A 0.221 0.382 0.127 0.068 0.670 0.103
ICGC_0209 Exome Bailey et al 2016 other 239.16 18.50 1.700 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0263 Exome Bailey et al 2016 other 167.50 36.27 1.700 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0504 Genome Bailey et al 2016 other 64.79 55.77 1.690 0.00 1 0 N/A 0.141 0.484 0.183 0.049 0.461 0.199
ICGC_0138 Genome Waddell et al 2015; Bailey et al 2016 other 89.57 45.20 1.689 0.00 1 1 2 2 N/A 0.148 0.243 0.072 0.031 0.273 0.779
ICGC_0235 Genome Waddell et al 2015; Bailey et al 2016 other 41.23 73.26 1.688 0.01 1 1 2 2 N/A 0.123 0.547 0.173 0.029 0.274 0.268
ICGC_0062 Genome Waddell et al 2015; Bailey et al 2016 other 74.89 98.55 1.688 0.49 0 1 2 2 N/A 0.104 0.500 0.112 0.029 0.396 0.354
ICGC_0058 Exome Bailey et al 2016 other 128.16 13.56 1.680 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0106 Exome Bailey et al 2016 other 200.55 41.11 1.680 0.11 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0224 Genome Bailey et al 2016 other 56.79 84.09 1.678 0.02 1 0 N/A 0.160 0.486 0.098 0.020 0.611 0.079
ICGC_0026 Genome Waddell et al 2015; Bailey et al 2016 other 51.73 80.17 1.669 0.09 1 1 2 2 N/A 0.142 0.522 0.229 0.045 0.452 0.100
ICGC_0053 Genome Bailey et al 2016 other 57.37 41.14 Germline BRCA2 c.5718_5719delCT, p.Leu1908ArgfsTer21.668 0.00 1 1 2 2 N/A 0.068 0.723 0.164 0.018 0.379 0.123
ICGC_0115 Genome Waddell et al 2015; Bailey et al 2016 other 84.81 57.29 1.664 0.00 1 1 2 2 N/A 0.139 0.660 0.079 0.066 0.443 0.115
ICGC_0278 Exome Bailey et al 2016 other 174.82 41.03 1.660 0.00 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0190 Exome Bailey et al 2016 other 142.63 43.75 1.640 0.01 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0223 Genome Waddell et al 2015; Bailey et al 2016 other 69.33 89.61 1.640 0.20 1 0 N/A 0.132 0.429 0.024 0.027 0.115 0.767
ICGC_0486 Genome Bailey et al 2016 other 75.59 80.85 1.640 0.01 1 0 N/A 0.112 0.827 0.148 0.024 0.290 0.040
ICGC_0169 Genome Waddell et al 2015; Bailey et al 2016 other 74.47 57.68 1.633 0.00 1 0 N/A 0.130 0.684 0.155 0.024 0.217 0.176
ICGC_0320 Genome Bailey et al 2016 other 60.98 80.58 Yes Not detected 1.630 0.00 1 0 N/A 0.253 0.398 0.179 0.086 0.474 0.064
ICGC_0004 Genome Waddell et al 2015; Bailey et al 2016 other 66.45 16.67 Yes Not detected 1.624 0.00 0 1 2 2 N/A 0.100 0.699 0.084 0.079 0.268 0.127
GARV_0658 Genome Bailey et al 2016 other 63.42 99.44 1.623 0.43 0 0 N/A 0.097 0.739 0.186 0.031 0.291 0.114
ICGC_0212 Genome Waddell et al 2015; Bailey et al 2016 other 71.83 55.61 1.617 0.00 1 0 N/A 0.132 0.661 0.183 0.046 0.334 0.069
ICGC_0342 Genome Bailey et al 2016 other 90.81 56.76 1.609 0.00 0 1 2 2 N/A 0.135 0.497 0.161 0.077 0.392 0.174
ICGC_0116 Genome Waddell et al 2015; Bailey et al 2016 other 66.22 60.03 1.609 0.01 0 1 2 2 N/A 0.160 0.502 0.138 0.060 0.410 0.147
ICGC_0188 Genome Waddell et al 2015; Bailey et al 2016 other 71.47 56.64 Yes Not detected 1.607 0.00 1 1 2 2 N/A 0.076 0.751 0.123 0.020 0.253 0.122
ICGC_0205 Genome Waddell et al 2015; Bailey et al 2016 other 72.03 68.09 Yes Not detected 1.601 0.00 1 0 N/A 0.107 0.563 0.087 0.063 0.528 0.108
ICGC_0030 Exome Bailey et al 2016 other 166.44 35.29 1.600 0.03 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0318 Exome Bailey et al 2016 other 203.35 33.39 1.600 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
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ICGC_0509 Genome Bailey et al 2016 other 72.66 93.09 1.588 1.86 0 0 N/A 0.166 0.660 0.098 0.035 0.382 0.137
ICGC_0206 Genome Waddell et al 2015; Bailey et al 2016 other 64.78 69.55 1.565 0.01 1 0 N/A 0.180 0.598 0.150 0.023 0.363 0.081
ICGC_0197 Exome Bailey et al 2016 other 216.94 29.81 1.560 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0305 Exome Bailey et al 2016 other 118.83 32.16 1.560 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0530 Exome Bailey et al 2016 other 211.89 35.10 1.560 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0315 Genome Waddell et al 2015; Bailey et al 2016 other 64.25 80.53 1.552 0.00 1 0 N/A 0.110 0.640 0.119 0.052 0.436 0.027
ICGC_0502 Genome Bailey et al 2016 other 73.60 60.93 1.545 0.01 1 0 N/A 0.057 0.818 0.101 0.029 0.249 0.093
ICGC_0312 Genome Waddell et al 2015; Bailey et al 2016 other 56.20 55.88 1.541 0.00 1 1 2 2 N/A 0.055 0.680 0.138 0.056 0.303 0.127
ICGC_0337 Exome Bailey et al 2016 other 191.00 37.21 Yes Not detected 1.540 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0412 Genome Bailey et al 2016 other 87.79 47.81 Yes Not detected 1.530 0.00 1 0 N/A 0.021 0.879 0.102 0.023 0.210 0.089
ICGC_0371 Genome Bailey et al 2016 other 89.70 60.92 1.524 0.01 1 0 N/A 0.155 0.511 0.088 0.066 0.520 0.029
ICGC_0295 Genome Waddell et al 2015; Bailey et al 2016 other 70.16 81.60 1.523 0.01 1 1 2 2 N/A 0.132 0.860 0.150 0.049 0.289 0.065
ICGC_0363 Exome Bailey et al 2016 other 175.90 29.16 1.520 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0346 Genome Bailey et al 2016 other 95.17 45.54 Yes Not detected 1.515 0.02 1 0 Normal Bethesda PCR panel N/A 0.037 0.760 0.098 0.024 0.321 0.078
ICGC_0289 Genome Waddell et al 2015; Bailey et al 2016 other 60.28 42.89 1.515 0.01 1 0 N/A 0.053 0.781 0.173 0.052 0.196 0.064
ICGC_0217 Genome Bailey et al 2016 other 54.08 61.59 1.501 0.00 1 1 2 2 N/A 0.096 0.529 0.074 0.119 0.267 0.255
ICGC_0017 Exome Bailey et al 2016 other 176.93 18.02 1.500 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0275 Exome Bailey et al 2016 other 145.37 18.02 1.500 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0380 Exome Bailey et al 2016 other 200.74 34.95 1.500 0.02 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0417 Genome Bailey et al 2016 other 95.28 53.55 1.498 0.00 1 1 2 2 N/A 0.127 0.664 0.164 0.051 0.299 0.025
ICGC_0292 Exome Bailey et al 2016 other 187.64 47.13 1.480 0.00 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0132 Exome Bailey et al 2016 other 164.35 36.11 1.460 0.00 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0317 Exome Bailey et al 2016 other 185.12 23.49 1.460 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0323 Exome Bailey et al 2016 other 193.38 25.11 1.460 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0340 Exome Bailey et al 2016 other 196.06 29.15 1.460 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0031 Genome Waddell et al 2015; Bailey et al 2016 other 57.59 45.40 1.445 0.00 1 1 2 2 N/A 0.065 0.544 0.102 0.021 0.438 0.168
ICGC_0391 Genome Bailey et al 2016 other 89.61 65.43 1.441 0.00 1 0 N/A 0.174 0.254 0.273 0.001 0.395 0.207
ICGC_0041 Exome Bailey et al 2016 other 171.83 14.27 1.440 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0096 Exome Bailey et al 2016 other 241.61 23.97 1.440 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0175 Exome Bailey et al 2016 other 216.23 18.06 Yes Not detected 1.440 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0345 Exome Bailey et al 2016 other 195.35 22.61 1.440 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0513 Genome Bailey et al 2016 other 58.09 48.52 1.440 0.00 1 0 N/A 0.206 0.407 0.157 0.046 0.347 0.098
ICGC_0368 Genome Bailey et al 2016 other 65.32 61.15 1.438 0.00 1 0 N/A 0.191 0.469 0.121 0.030 0.372 0.080
ICGC_0040 Genome Waddell et al 2015; Bailey et al 2016 other 46.25 99.52 1.427 0.17 0 1 2 2 N/A 0.096 0.576 0.139 0.031 0.295 0.091
ICGC_0135 Genome Waddell et al 2015; Bailey et al 2016 other 94.94 40.22 1.422 0.00 1 1 2 2 N/A 0.142 0.621 0.120 0.040 0.173 0.152
ICGC_0162 Exome Bailey et al 2016 other 175.97 39.25 Yes Not detected 1.420 0.00 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0260 Exome Bailey et al 2016 other 153.93 19.60 1.420 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0124 Genome Bailey et al 2016 other 65.38 60.21 1.419 0.00 0 1 2 2 N/A 0.108 0.545 0.087 0.054 0.373 0.105
ICGC_0521 Genome Bailey et al 2016 other 68.29 77.50 1.412 0.01 1 0 N/A 0.113 0.449 0.193 0.036 0.389 0.068
ICGC_0007 Genome Waddell et al 2015; Bailey et al 2016 other 50.15 53.41 1.402 0.00 1 1 2 2 N/A 0.099 0.618 0.082 0.035 0.243 0.113
ICGC_0101 Exome Bailey et al 2016 other 219.23 14.78 1.400 0.01 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0125 Exome Bailey et al 2016 other 157.67 33.24 1.400 0.01 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0203 Exome Bailey et al 2016 other 147.74 44.49 1.400 0.00 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0252 Exome Bailey et al 2016 other 212.63 18.58 1.400 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0280 Exome Bailey et al 2016 other 142.02 15.46 1.380 0.01 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0020 Genome Bailey et al 2016 other 70.62 80.40 1.379 0.01 1 1 2 2 N/A 0.028 0.809 0.109 0.037 0.156 0.041
ICGC_0098 Genome Waddell et al 2015; Bailey et al 2016 other 60.16 98.74 1.372 0.14 0 0 N/A 0.122 0.476 0.074 0.064 0.366 0.120
ICGC_0121 Genome Waddell et al 2015; Bailey et al 2016 other 68.59 60.05 1.368 0.00 1 1 2 2 N/A 0.031 0.728 0.101 0.028 0.202 0.111
ICGC_0055 Genome Waddell et al 2015; Bailey et al 2016 other 63.39 60.17 1.362 0.00 1 1 0 2 2 MSH6,  2 MSH2, 0 PMS2, 1 MLH1N/A 0.120 0.478 0.170 0.032 0.305 0.062
ICGC_0230 Genome Bailey et al 2016 other 62.19 71.16 1.361 0.01 1 0 N/A 0.082 0.376 0.064 0.032 0.589 0.032
ICGC_0092 Exome Bailey et al 2016 other 190.72 32.64 1.360 0.03 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0025 Genome Waddell et al 2015; Bailey et al 2016 other 66.43 61.95 1.359 0.01 1 0 N/A 0.146 0.404 0.086 0.074 0.350 0.155
ICGC_0377 Genome Bailey et al 2016 other 93.82 46.97 1.357 0.00 0 0 N/A 0.167 0.386 0.103 0.064 0.340 0.114
ICGC_0214 Genome Waddell et al 2015; Bailey et al 2016 other 65.18 54.89 1.353 0.00 1 1 2 2 N/A 0.103 0.507 0.095 0.018 0.301 0.178
ICGC_0313 Genome Bailey et al 2016 other 71.86 50.40 1.349 0.00 1 0 N/A 0.041 0.728 0.106 0.015 0.184 0.099
ICGC_0535 Genome Bailey et al 2016 other 58.63 54.02 1.342 0.00 1 0 N/A 0.068 0.448 0.082 0.263 0.254 0.150
ICGC_0288 Exome Bailey et al 2016 other 210.46 41.43 1.340 0.02 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0378 Exome Bailey et al 2016 other 109.12 30.97 1.340 0.01 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0388 Exome Bailey et al 2016 other 118.17 39.09 1.340 0.00 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0543 Genome Bailey et al 2016 other 68.88 63.61 1.339 0.00 1 0 N/A 0.097 0.473 0.077 0.030 0.331 0.183
ICGC_0365 Genome Bailey et al 2016 other 100.02 55.14 1.334 0.00 1 0 N/A 0.127 0.366 0.092 0.146 0.256 0.184
ICGC_0032 Genome Waddell et al 2015; Bailey et al 2016 other 56.56 99.42 1.323 0.49 0 1 2 2 2 MSH6, 2 MSH2, 2 PMS2, 1 MLH1N/A 0.145 0.426 0.152 0.037 0.269 0.108
ICGC_0199 Genome Waddell et al 2015; Bailey et al 2016 other 63.85 79.74 1.321 0.00 1 1 2 2 N/A 0.122 0.413 0.096 0.078 0.367 0.099
ICGC_0350 Exome Bailey et al 2016 other 192.22 31.72 1.320 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0387 Genome Bailey et al 2016 other 60.23 45.35 1.319 0.00 1 0 N/A 0.137 0.348 0.083 0.205 0.316 0.072
ICGC_0066 Genome Waddell et al 2015; Bailey et al 2016 other 58.78 65.03 1.311 0.01 1 1 2 2 N/A 0.211 0.213 0.165 0.047 0.439 0.102
GARV_0660 Genome Bailey et al 2016 other 68.20 99.23 1.308 0.72 0 0 N/A 0.063 0.659 0.140 0.018 0.207 0.049
ICGC_0049 Exome Bailey et al 2016 other 142.64 22.70 1.300 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0173 Exome Bailey et al 2016 other 201.17 36.40 1.300 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
GARV_0671 Genome Bailey et al 2016 other 60.21 98.46 1.290 1.18 0 0 N/A 0.096 0.396 0.079 0.021 0.385 0.176
ICGC_0057 Exome Bailey et al 2016 other 147.73 40.35 1.280 0.00 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0082 Exome Bailey et al 2016 other 209.36 27.11 1.280 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0097 Exome Bailey et al 2016 other 259.24 20.24 1.280 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0102 Exome Bailey et al 2016 other 141.67 16.77 Yes Not detected 1.280 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0354 Genome Bailey et al 2016 other 96.84 82.08 Somatic BRCA2 chr13:g.32918736AGGATAATAGAAAATCAAGAAAAATCCTTAA>-1.280 0.12 1 0 N/A 0.095 0.364 0.117 0.027 0.376 0.161
ICGC_0143 Genome Waddell et al 2015; Bailey et al 2016 other 87.74 51.87 1.263 0.00 1 1 2 2 N/A 0.127 0.564 0.061 0.066 0.166 0.145
ICGC_0012 Exome Bailey et al 2016 other 62.34 41.38 1.260 0.00 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0191 Exome Bailey et al 2016 other 133.10 41.97 1.260 0.00 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0154 Genome Waddell et al 2015; Bailey et al 2016 other 69.00 42.72 1.248 0.00 1 1 2 2 N/A 0.032 0.499 0.083 0.007 0.132 0.360
ICGC_0018 Exome Bailey et al 2016 other 54.80 37.07 1.240 0.00 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0310 Exome Bailey et al 2016 other 169.27 16.02 1.240 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0300 Genome Waddell et al 2015; Bailey et al 2016 other 61.13 64.46 1.239 0.01 1 1 2 2 N/A 0.132 0.519 0.107 0.038 0.231 0.045
ICGC_0112 Exome Bailey et al 2016 other 175.89 34.23 1.220 0.00 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0147 Exome Bailey et al 2016 other 196.61 19.53 1.220 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0182 Genome Waddell et al 2015; Bailey et al 2016 other 42.24 81.19 1.215 0.01 1 1 2 2 2 MSH6,  2 MSH2, 2 PMS2, 2 MLH1N/A 0.123 0.466 0.092 0.031 0.215 0.133
GARV_0664 Genome Bailey et al 2016 other 41.40 99.17 1.205 0.10 0 0 N/A 0.129 0.353 0.131 0.027 0.267 0.155
ICGC_0269 Exome Bailey et al 2016 other 163.12 23.27 1.180 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0271 Exome Bailey et al 2016 other 203.65 34.82 1.180 0.04 1 0 N/A N/A N/A N/A N/A N/A N/A
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ICGC_0255 Genome Waddell et al 2015; Bailey et al 2016 other 65.54 70.38 1.165 0.00 1 0 N/A 0.119 0.351 0.078 0.046 0.368 0.077
ICGC_0148 Exome Bailey et al 2016 other 176.89 18.92 1.160 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0402 Exome Bailey et al 2016 other 197.82 31.97 1.160 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0159 Exome Bailey et al 2016 other 172.07 35.54 1.140 0.00 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0185 Genome Waddell et al 2015; Bailey et al 2016 other 68.88 56.17 1.123 0.00 1 1 2 2 N/A 0.078 0.379 0.053 0.094 0.306 0.104
ICGC_0234 Exome Bailey et al 2016 other 170.27 19.62 1.120 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0369 Exome Bailey et al 2016 other 91.44 25.34 1.120 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0201 Genome Waddell et al 2015; Bailey et al 2016 other 72.82 83.88 1.113 0.00 1 1 2 2 N/A 0.133 0.334 0.078 0.033 0.360 0.072
ICGC_0048 Genome Bailey et al 2016 other 81.00 62.31 1.108 0.01 1 1 2 2 N/A 0.169 0.313 0.056 0.033 0.266 0.155
ICGC_0047 Exome Bailey et al 2016 other 100.30 34.64 1.100 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0383 Exome Bailey et al 2016 other 157.04 33.79 1.100 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0139 Genome Waddell et al 2015; Bailey et al 2016 other 90.11 70.41 1.100 0.01 1 1 2 2 N/A 0.107 0.440 0.059 0.038 0.272 0.041
ICGC_0023 Exome Bailey et al 2016 other 145.94 21.96 1.080 0.01 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0259 Exome Bailey et al 2016 other 144.38 43.67 1.080 0.01 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0152 Genome Bailey et al 2016 other 68.19 50.09 1.070 0.00 1 1 2 2 N/A 0.120 0.409 0.080 0.008 0.253 0.075
ICGC_0257 Genome Waddell et al 2015; Bailey et al 2016 other 67.10 53.00 1.069 0.00 1 0 N/A 0.050 0.519 0.070 0.044 0.229 0.041
ICGC_0039 Exome Bailey et al 2016 other 131.58 41.30 1.060 0.00 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0123 Exome Bailey et al 2016 other 139.33 39.42 1.060 0.00 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0253 Exome Bailey et al 2016 other 188.31 34.93 1.060 0.00 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0302 Exome Bailey et al 2016 other 181.00 23.45 1.060 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0336 Exome Bailey et al 2016 other 203.96 30.27 1.060 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0385 Exome Bailey et al 2016 other 176.21 39.51 1.060 0.02 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0507 Genome Bailey et al 2016 other 80.48 53.18 1.053 0.00 1 0 N/A 0.133 0.335 0.073 0.016 0.283 0.076
ICGC_0239 Genome Waddell et al 2015; Bailey et al 2016 other 59.17 56.97 1.041 0.00 1 0 N/A 0.053 0.485 0.104 0.025 0.194 0.037
ICGC_0314 Exome Bailey et al 2016 other 185.92 16.61 1.040 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0064 Exome Bailey et al 2016 other 47.80 36.65 1.020 0.00 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0381 Exome Bailey et al 2016 other 101.58 29.09 1.020 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0503 Genome Bailey et al 2016 other 74.29 45.94 1.014 0.00 1 0 N/A 0.064 0.499 0.062 0.032 0.216 0.018
ICGC_0301 Genome Bailey et al 2016 other 93.81 70.27 1.002 0.01 1 1 2 2 N/A 0.173 0.311 0.059 0.021 0.299 0.015
ICGC_0270 Exome Bailey et al 2016 other 165.56 17.25 0.980 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0274 Exome Bailey et al 2016 other 315.69 29.35 0.980 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0403 Exome Bailey et al 2016 other 135.10 16.65 0.980 0.02 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0242 Genome Waddell et al 2015; Bailey et al 2016 other 67.90 66.39 0.973 0.00 1 0 N/A 0.082 0.479 0.058 0.005 0.168 0.063
ICGC_0009 Genome Waddell et al 2015; Bailey et al 2016 other 59.49 71.35 0.949 0.00 1 1 2 2 N/A 0.047 0.445 0.054 0.025 0.182 0.013
ICGC_0518 Genome Bailey et al 2016 other 63.40 48.08 0.935 0.00 1 0 N/A 0.039 0.395 0.097 0.025 0.157 0.117
ICGC_0108 Genome Bailey et al 2016 other 50.89 50.93 0.923 0.00 1 0 N/A 0.085 0.262 0.058 0.014 0.291 0.110
ICGC_0520 Exome Bailey et al 2016 other 143.62 17.06 0.920 0.01 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0144 Genome Waddell et al 2015; Bailey et al 2016 other 76.66 58.27 0.903 0.00 1 1 2 2 N/A 0.047 0.473 0.069 0.017 0.101 0.070
ICGC_0027 Exome Bailey et al 2016 other 113.13 17.13 0.900 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0104 Exome Bailey et al 2016 other 198.31 15.52 0.900 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0373 Exome Bailey et al 2016 other 157.88 19.99 0.900 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0408 Exome Bailey et al 2016 other 107.27 18.75 0.900 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0505 Exome Bailey et al 2016 other 179.30 16.05 0.900 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0110 Exome Bailey et al 2016 other 134.95 17.04 0.860 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0165 Exome Bailey et al 2016 other 156.56 19.49 0.860 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0179 Exome Bailey et al 2016 other 107.95 17.18 0.860 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0216 Exome Bailey et al 2016 other 139.94 41.80 0.860 0.00 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0493 Exome Bailey et al 2016 other 181.26 19.78 0.860 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0219 Exome Bailey et al 2016 other 150.40 16.60 0.840 0.02 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0279 Exome Bailey et al 2016 other 241.77 24.69 0.840 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0241 Exome Bailey et al 2016 other 164.18 16.16 0.820 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0360 Exome Bailey et al 2016 other 176.37 30.99 0.820 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0396 Exome Bailey et al 2016 other 252.33 18.54 0.820 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0011 Exome Bailey et al 2016 other 89.14 37.92 0.800 0.00 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0019 Exome Bailey et al 2016 other 195.40 22.97 0.780 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0307 Exome Bailey et al 2016 other 202.56 17.86 0.780 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0045 Exome Bailey et al 2016 other 48.54 38.81 0.740 0.00 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0294 Exome Bailey et al 2016 other 178.15 17.57 0.740 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0370 Exome Bailey et al 2016 other 159.46 17.37 0.740 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0146 Genome Waddell et al 2015; Bailey et al 2016 other 84.97 47.69 0.732 0.00 1 1 2 2 N/A 0.077 0.203 0.028 0.012 0.185 0.112
ICGC_0187 Exome Bailey et al 2016 other 162.71 26.58 0.660 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0010 Exome Bailey et al 2016 other 30.79 39.11 0.620 0.00 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0210 Exome Bailey et al 2016 other 192.19 22.88 0.620 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0079 Exome Bailey et al 2016 other 238.79 14.49 0.600 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0251 Exome Bailey et al 2016 other 189.39 16.24 0.600 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0267 Exome Bailey et al 2016 other 132.44 20.43 0.600 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0414 Exome Bailey et al 2016 other 223.71 15.69 0.600 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
GARV_0670 Genome Bailey et al 2016 other 54.90 98.81 0.586 0.65 0 0 N/A 0.010 0.116 0.019 0.004 0.022 0.066
ICGC_0024 Exome Bailey et al 2016 other 161.61 19.16 Yes Not detected 0.580 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0343 Exome Bailey et al 2016 other 174.23 16.06 0.580 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0508 Exome Bailey et al 2016 other 247.29 16.62 0.560 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0246 Exome Bailey et al 2016 other 152.78 25.22 0.540 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0372 Exome Bailey et al 2016 other 138.90 16.25 0.520 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0050 Genome Bailey et al 2016 other 57.86 12.25 Yes Not detected 0.509 0.00 0 1 2 2 N/A 0.015 0.272 0.031 0.014 0.078 0.033
ICGC_0258 Exome Bailey et al 2016 other 181.61 30.92 0.500 0.00 1 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0164 Exome Bailey et al 2016 other 172.13 15.54 0.480 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0407 Exome Bailey et al 2016 other 184.23 17.28 0.480 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0238 Exome Bailey et al 2016 other 115.68 23.09 0.460 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0362 Exome Bailey et al 2016 other 107.55 21.45 0.460 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0028 Exome Bailey et al 2016 other 101.99 34.51 0.440 0.00 1 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0136 Exome Bailey et al 2016 other 215.88 17.49 0.440 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0382 Exome Bailey et al 2016 other 91.44 24.38 0.440 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0405 Exome Bailey et al 2016 other 120.08 17.21 0.440 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0003 Exome Bailey et al 2016 other 199.57 24.81 0.420 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0111 Exome Bailey et al 2016 other 188.29 16.39 0.420 0.01 0 1 1 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0202 Exome Bailey et al 2016 other 135.91 19.67 0.420 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0311 Exome Bailey et al 2016 other 180.57 16.55 0.420 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0394 Exome Bailey et al 2016 other 224.53 25.60 0.420 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
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ICGC_0488 Exome Bailey et al 2016 other 151.40 16.54 0.420 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0389 Exome Bailey et al 2016 other 143.96 19.38 0.400 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0157 Exome Bailey et al 2016 other 103.29 18.89 0.380 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0254 Exome Bailey et al 2016 other 122.17 17.59 0.380 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0265 Exome Bailey et al 2016 other 122.22 21.56 0.380 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0361 Exome Bailey et al 2016 other 208.06 15.66 0.380 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
GARV_0674 Genome Bailey et al 2016 other 62.21 99.36 0.320 0.41 0 0 N/A 0.011 0.068 0.013 0.004 0.021 0.004
ICGC_0243 Exome Bailey et al 2016 other 182.21 17.94 0.320 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0352 Exome Bailey et al 2016 other 183.93 19.29 0.300 0.01 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0022 Exome Bailey et al 2016 other 181.35 18.94 0.280 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0133 Exome Bailey et al 2016 other 145.17 19.78 0.280 0.01 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0170 Exome Bailey et al 2016 other 162.32 16.90 0.280 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0411 Exome Bailey et al 2016 other 173.32 15.38 0.280 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
GARV_0673 Genome Bailey et al 2016 other 60.25 99.03 0.272 0.32 0 0 N/A 0.008 0.068 0.011 0.003 0.023 0.003
ICGC_0240 Exome Bailey et al 2016 other 115.82 17.21 0.260 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0195 Exome Bailey et al 2016 other 168.74 27.69 0.240 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0226 Exome Bailey et al 2016 other 131.92 20.96 Yes Not detected 0.220 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0247 Exome Bailey et al 2016 other 162.86 16.97 0.220 0.01 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0001 Exome NA other 208.92 16.56 0.200 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0094 Exome Bailey et al 2016 other 222.53 15.50 0.200 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0404 Exome Bailey et al 2016 other 98.15 18.45 0.180 0.01 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0266 Exome Bailey et al 2016 other 104.54 17.67 0.160 0.01 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0399 Exome Bailey et al 2016 other 188.38 16.28 0.160 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0264 Exome Bailey et al 2016 other 181.07 17.30 0.140 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0308 Exome Bailey et al 2016 other 164.87 16.16 0.140 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0398 Exome Bailey et al 2016 other 107.46 20.15 0.140 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0401 Exome Bailey et al 2016 other 144.51 16.91 0.140 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0014 Exome NA other 156.48 20.14 0.120 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0083 Exome NA other 223.47 16.13 0.120 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0347 Exome Bailey et al 2016 other 176.77 15.54 0.120 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0038 Exome Bailey et al 2016 other 136.95 14.33 0.100 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0167 Exome NA other 137.57 23.41 0.100 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0071 Exome Bailey et al 2016 other 223.67 16.44 0.080 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0091 Exome NA other 182.74 16.33 0.080 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0117 Exome Bailey et al 2016 other 66.34 20.45 0.080 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0180 Exome Bailey et al 2016 other 152.34 15.99 0.080 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
ICGC_0358 Exome Bailey et al 2016 other 161.86 17.19 0.080 0.00 0 0 N/A N/A N/A N/A N/A N/A N/A
ICGC_0095 Exome Bailey et al 2016 other 196.10 15.89 0.060 0.00 0 1 2 2 N/A N/A N/A N/A N/A N/A N/A
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